Skip to main content

Advertisement

ADVERTISEMENT

Podcasts

Headshot of Adam Kittai, Ohio State University, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
12/14/2021
Maria Asimopoulos
In part two of this podcast series, Adam Kittai, MD, hematologist and assistant professor of medicine, Ohio State University, highlights findings from the CAPTIVATE study regarding the efficacy of ibrutinib vs placebo for disease-free...
In part two of this podcast series, Adam Kittai, MD, hematologist and assistant professor of medicine, Ohio State University, highlights findings from the CAPTIVATE study regarding the efficacy of ibrutinib vs placebo for disease-free...
In part two of this podcast...
12/14/2021
First Report Managed Care
Headshot of Adam Kittai, Ohio State University, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
12/14/2021
Maria Asimopoulos
In part one of this podcast series, Adam Kittai, MD, hematologist and assistant professor of medicine, Ohio State University, provides an overview of current research being conducted on chronic lymphocytic leukemia and discusses the results...
In part one of this podcast series, Adam Kittai, MD, hematologist and assistant professor of medicine, Ohio State University, provides an overview of current research being conducted on chronic lymphocytic leukemia and discusses the results...
In part one of this podcast...
12/14/2021
First Report Managed Care
Headshot of Martin Edelman, Fox Chase Cancer Center, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
12/10/2021
Maria Asimopoulos
Martin Edelman, MD, chair, Department of Hematology/Oncology, deputy director of clinical research, Fox Chase Cancer Center, discusses the disease burden of non-small cell lung cancer, as well as the findings from a phase 3 trial that...
Martin Edelman, MD, chair, Department of Hematology/Oncology, deputy director of clinical research, Fox Chase Cancer Center, discusses the disease burden of non-small cell lung cancer, as well as the findings from a phase 3 trial that...
Martin Edelman, MD, chair,...
12/10/2021
First Report Managed Care

Advertisement

Headshot of Saad Usmani, Memorial Sloan Kettering Cancer Center, on a blue background underneath PopHealth Perspectives logo
Podcasts
12/09/2021
Maria Asimopoulos
Samantha Matthews
Saad Usmani, MD, MBA, FACP, chief of myeloma service, Memorial Sloan Kettering Cancer Center, discusses current challenges in treating multiple myeloma, financial burdens associated with this type of cancer, and where the future of care may...
Saad Usmani, MD, MBA, FACP, chief of myeloma service, Memorial Sloan Kettering Cancer Center, discusses current challenges in treating multiple myeloma, financial burdens associated with this type of cancer, and where the future of care may...
Saad Usmani, MD, MBA, FACP,...
12/09/2021
First Report Managed Care
Headshot of Edmund Pezalla, Enlightenment Bioconsult, LLC, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
12/03/2021
Maria Asimopoulos
Ed Pezalla, MD, MPH, chief executive officer, Enlightenment Bioconsult, LLC, offers insight on the disease burden and costs associated with systemic lupus erythematosus, as well as how payers can support patients seeking testing and treatment.
Ed Pezalla, MD, MPH, chief executive officer, Enlightenment Bioconsult, LLC, offers insight on the disease burden and costs associated with systemic lupus erythematosus, as well as how payers can support patients seeking testing and treatment.
Ed Pezalla, MD, MPH, chief...
12/03/2021
First Report Managed Care
Headshot of Gil Melmed, Cedars Sinai, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
11/30/2021
Maria Asimopoulos
Gil Melmed, MD, gastroenterologist, Cedars Sinai, Los Angeles, provides insight on fecal microbiota transplantation, including its cost-effectiveness, limitations, and use in treating gastrointestinal diseases such as Clostridioides difficile.
Gil Melmed, MD, gastroenterologist, Cedars Sinai, Los Angeles, provides insight on fecal microbiota transplantation, including its cost-effectiveness, limitations, and use in treating gastrointestinal diseases such as Clostridioides difficile.
Gil Melmed, MD,...
11/30/2021
First Report Managed Care

Advertisement

Headshot of Nasser Altorki, MD, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
11/09/2021
Julie Gould
Maria Asimopoulos
Nasser Altorki, MD, chief of thoracic surgery, New York Presbyterian-Weill Cornell Medicine, discusses the findings from the IMpower010 study, in which adjuvant atezolizumab resulted in a disease-free survival benefit that was superior to...
Nasser Altorki, MD, chief of thoracic surgery, New York Presbyterian-Weill Cornell Medicine, discusses the findings from the IMpower010 study, in which adjuvant atezolizumab resulted in a disease-free survival benefit that was superior to...
Nasser Altorki, MD, chief of...
11/09/2021
First Report Managed Care
Podcast
10/29/2021
Edan Stanley
Karen Ferguson, MS, former practice administrator, consultant, and cofounder and CEO of Discus Analytics, Inc, discusses the role value-based care models have to play in transforming rheumatology care, including their effects on costs,...
Karen Ferguson, MS, former practice administrator, consultant, and cofounder and CEO of Discus Analytics, Inc, discusses the role value-based care models have to play in transforming rheumatology care, including their effects on costs,...
Karen Ferguson, MS, former...
10/29/2021
First Report Managed Care
norm smith, viewpoint consulting
Podcasts
10/20/2021
Julie Gould
Norm Smith, former president, Viewpoint Consulting, reflects on a project where his company was once asked to look at reimbursement models linked with C difficile vaccines in countries outside of the United States, and highlights why this is...
Norm Smith, former president, Viewpoint Consulting, reflects on a project where his company was once asked to look at reimbursement models linked with C difficile vaccines in countries outside of the United States, and highlights why this is...
Norm Smith, former president,...
10/20/2021
First Report Managed Care

Advertisement

Ajai Chari, MD, professor of medicine, hematology, and medical oncology, Mount Sinai,
Podcasts
10/20/2021
Maria Asimopoulos
Julie Gould
Ajai Chari, MD, professor of medicine, hematology, and medical oncology, Mount Sinai, discusses the unmet need in multiple myeloma (MM), challenges specific to treating this disease, why MM is becoming one of the most costly cancers to treat,...
Ajai Chari, MD, professor of medicine, hematology, and medical oncology, Mount Sinai, discusses the unmet need in multiple myeloma (MM), challenges specific to treating this disease, why MM is becoming one of the most costly cancers to treat,...
Ajai Chari, MD, professor of...
10/20/2021
First Report Managed Care

Advertisement